Gland Pharma shares rose over 1% after Deepak Sapra was named CEO. He will take charge on November 16, 2026. The company also reported a 47.1% jump in Q1 FY27 net profit.
Gland Pharma shares rose over 1% after Deepak Sapra was named CEO. He will take charge on November 16, 2026. The company also reported a 47.1% jump in Q1 FY27 net profit.